Results 131 to 140 of about 25,475 (182)

Joint modeling of progression-free survival and patient-reported outcomes to evaluate the association between disease progression and symptoms among patients with relapsed/refractory multiple myeloma. [PDF]

J Patient Rep Outcomes
Knop S, Einsele H, Dhanda D, Marshall TS, Eliason L, McLoone D, Caisip C, Chen JMH, Boehm D, Dhamane AD, Ramasamy K, Cope S, Towle K.   +12 more
europepmc   +1 more source

Do all patients with early breast cancer meeting the NATALEE criteria benefit from adjuvant ribociclib? [PDF]

ESMO Open
Valenza C, Trapani D, Curigliano G.
europepmc   +1 more source

Permutation Tests Based on the Copula-Graphic Estimator and Their Use for Survival Tree Construction. [PDF]

Stat Med
Baur P, Pauly M, Emura T.
europepmc   +1 more source

Testing for Sufficient Follow-Up in Survival Data With a Cure Fraction. [PDF]

Biom J
Yuen TP, Musta E.
europepmc   +1 more source

Literature-informed ensemble machine learning for three-year diabetic kidney disease risk prediction in type 2 diabetes: Development, validation, and deployment of the PSMMC NephraRisk model. [PDF]

Diabetes Obes Metab
Tourkmani AM, Al-Harbi TJ, Alghamdi AA, Youzghadli IM, Alosaimi FS, Azzam AY.   +5 more
europepmc   +1 more source

New, Shorter Small-Sample Intervals for Vaccine Efficacy. [PDF]

Pharm Stat
Gasparini M, Trani VD, Ratta M.
europepmc   +1 more source

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis. [PDF]

J Neurol Neurosurg Psychiatry
Gavoille A, Nourredine M, Rollot F, Casey R, Mathey G, Kerbrat A, Ciron J, De Sèze J, Stankoff B, Maillart E, Ruet A, Labauge P, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanché JP, Doghri I, Sarov M, Hankiewicz K, Pottier C, Dos Santos A, Manchon E, Tchikviladze M, Rabilloud M, Subtil F, Vukusic S.   +40 more
europepmc   +1 more source

Estimating treatment effects on duration with disease: a principal stratification framework. [PDF]

Lifetime Data Anal
Parner ET.
europepmc   +1 more source

Covariate-Adjusted Group Sequential Comparisons of Survival Probabilities. [PDF]

Stat Med
Zhang P, Logan B, Martens MJ.
europepmc   +1 more source

A decomposition of Fisher's information to inform sample size for developing or updating fair and precise clinical prediction models - part 2: time-to-event outcomes. [PDF]

Diagn Progn Res
Riley RD, Collins GS, Archer L, Whittle R, Legha A, Kirton L, Dhiman P, Sadatsafavi M, Adderley NJ, Alderman J, Martin GP, Ensor J.   +11 more
europepmc   +1 more source